FBT.L vs. VGVF.DE
FBT.L (First Trust NYSE Arca Biotechnology UCITS ETF Acc) and VGVF.DE (Vanguard FTSE Developed World UCITS ETF Acc) are both exchange-traded funds - FBT.L is a Health & Biotech Equities fund tracking the NASDAQ Biotechnology TR USD, while VGVF.DE is a Global Equities fund tracking the FTSE Developed. Both are passively managed. Over the past 5 years, FBT.L returned 7.17%/yr vs 13.31%/yr for VGVF.DE. At a 0.35 correlation, their price movements are largely independent. FBT.L charges 0.60%/yr vs 0.12%/yr for VGVF.DE.
Performance
FBT.L vs. VGVF.DE - Performance Comparison
Loading charts...
Different Trading Currencies
FBT.L is traded in GBp, while VGVF.DE is traded in EUR. To make them comparable, the VGVF.DE values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, FBT.L achieves a 4.41% return, which is significantly lower than VGVF.DE's 11.76% return.
FBT.L
- 1D
- 1.98%
- 1M
- 8.09%
- YTD
- 4.41%
- 6M
- 1.93%
- 1Y
- 34.35%
- 3Y*
- 9.80%
- 5Y*
- 7.17%
- 10Y*
- —
VGVF.DE
- 1D
- -0.39%
- 1M
- 6.38%
- YTD
- 11.76%
- 6M
- 12.52%
- 1Y
- 30.35%
- 3Y*
- 18.61%
- 5Y*
- 13.31%
- 10Y*
- —
FBT.L vs. VGVF.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
FBT.L First Trust NYSE Arca Biotechnology UCITS ETF Acc | 4.41% | 17.24% | 7.13% | -0.99% | 3.88% | -2.57% | -2.54% |
VGVF.DE Vanguard FTSE Developed World UCITS ETF Acc | 11.76% | 14.67% | 19.29% | 17.95% | -8.85% | 22.33% | 16.83% |
Correlation
The correlation between FBT.L and VGVF.DE is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.44 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.33 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.36 |
Correlation (All Time) Calculated using the full available price history since Jun 16, 2020 | 0.35 |
The correlation between FBT.L and VGVF.DE shifts across timeframes, from 0.33 (3 years) to 0.44 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FBT.L vs. VGVF.DE — Risk / Return Rank
FBT.L
VGVF.DE
FBT.L vs. VGVF.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) and Vanguard FTSE Developed World UCITS ETF Acc (VGVF.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBT.L | VGVF.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.10 | ||
| Sortino ratioReturn per unit of downside risk | -1.33 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 1.52 | -0.23 |
| Calmar ratioReturn relative to maximum drawdown | 2.48 | 4.41 | -1.93 |
| Martin ratioReturn relative to average drawdown | 6.60 | 17.87 | -11.27 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FBT.L | VGVF.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.70 | 2.80 | -1.10 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.45 | 0.97 | -0.52 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.26 | 0.85 | -0.59 |
Drawdowns
FBT.L vs. VGVF.DE - Drawdown Comparison
The maximum FBT.L drawdown since its inception was -30.39%, which is greater than VGVF.DE's maximum drawdown of -26.11%. Use the drawdown chart below to compare losses from any high point for FBT.L and VGVF.DE.
Loading charts...
Drawdown Indicators
| FBT.L | VGVF.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.39% | -26.11% | -4.28% |
Max Drawdown (1Y)Largest decline over 1 year | -13.81% | -6.85% | -6.96% |
Max Drawdown (3Y)Largest decline over 3 years | -23.70% | -19.43% | -4.27% |
Max Drawdown (5Y)Largest decline over 5 years | -23.70% | -19.43% | -4.27% |
Current DrawdownCurrent decline from peak | -1.97% | -0.39% | -1.58% |
Average DrawdownAverage peak-to-trough decline | -13.45% | -3.47% | -9.98% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.19% | 1.69% | +3.50% |
Volatility
FBT.L vs. VGVF.DE - Volatility Comparison
First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) has a higher volatility of 6.10% compared to Vanguard FTSE Developed World UCITS ETF Acc (VGVF.DE) at 3.25%. This indicates that FBT.L's price experiences larger fluctuations and is considered to be riskier than VGVF.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FBT.L | VGVF.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.10% | 3.25% | +2.85% |
Volatility (6M)Calculated over the trailing 6-month period | 15.02% | 7.89% | +7.13% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.11% | 10.80% | +9.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.49% | 13.54% | +8.95% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.86% | 15.52% | +8.34% |
FBT.L vs. VGVF.DE - Expense Ratio Comparison
FBT.L has a 0.60% expense ratio, which is higher than VGVF.DE's 0.12% expense ratio.
Dividends
FBT.L vs. VGVF.DE - Dividend Comparison
Neither FBT.L nor VGVF.DE has paid dividends to shareholders.
Frequently Asked Questions
FBT.L and VGVF.DE have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, VGVF.DE is cheaper at 0.12% per year. The better choice depends on whether you care most about return, fees, risk, or income.
VGVF.DE is cheaper with a 0.12% expense ratio, compared with 0.60% for FBT.L.
FBT.L is categorized as Health & Biotech Equities, while VGVF.DE is Global Equities. FBT.L tracks NASDAQ Biotechnology TR USD, while VGVF.DE tracks FTSE Developed. They also come from different issuers: First Trust and Vanguard. Their fees differ too: 0.60% for FBT.L and 0.12% for VGVF.DE.
Find the right allocation for FBT.L and VGVF.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer